Rubius Therapeutics Statistics Share Statistics Rubius Therapeutics has 0
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding n/a Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 85.39M Failed to Deliver (FTD) Shares 1 FTD / Avg. Volume n/a
Short Selling Information Short Interest n/a Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) n/a
Valuation Ratios The PE ratio is -0.07 and the forward
PE ratio is null.
Rubius Therapeutics's PEG ratio is
0.
PE Ratio -0.07 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 1.04 P/FCF Ratio -0.1 PEG Ratio 0
Financial Ratio History Enterprise Valuation Rubius Therapeutics has an Enterprise Value (EV) of 2.04M.
EV / Sales 0 EV / EBITDA -0.02 EV / EBIT -0.01 EV / FCF -0.01
Financial Position The company has a current ratio of 2.54,
with a Debt / Equity ratio of 0.07.
Current Ratio 2.54 Quick Ratio 2.54 Debt / Equity 0.07 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage -46.19
Financial Efficiency Return on Equity is -1525.76% and Return on Invested Capital is -1412.7%.
Return on Equity -1525.76% Return on Assets -1000.71% Return on Invested Capital -1412.7% Revenue Per Employee n/a Profits Per Employee $-38.48M Employee Count 6 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 51.2M Effective Tax Rate -28.5%
Stock Price Statistics The stock price has increased by 5.26% in the
last 52 weeks. The beta is 2.21, so Rubius Therapeutics's
price volatility has been higher than the market average.
Beta 2.21 52-Week Price Change 5.26% 50-Day Moving Average 0.02 200-Day Moving Average 0.02 Relative Strength Index (RSI) 87.52 Average Volume (20 Days) 99,535
Income Statement
Revenue n/a Gross Profit n/a Operating Income -178.45M Net Income -230.86M EBITDA -118.35M EBIT -175.8M Earnings Per Share (EPS) -2.56
Full Income Statement Balance Sheet The company has 14.87M in cash and 1.1M in
debt, giving a net cash position of 13.77M.
Cash & Cash Equivalents 14.87M Total Debt 1.1M Net Cash 13.77M Retained Earnings -856.68M Total Assets 23.07M Working Capital 12.26M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -150.14M
and capital expenditures -5.3M, giving a free cash flow of -155.45M.
Operating Cash Flow -150.14M Capital Expenditures -5.3M Free Cash Flow -155.45M FCF Per Share -1.72
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
